Aegon Ltd. vs Eli Lilly And Co — how do they compare? Aegon Ltd. trades at $9.4 (market cap $14.01B), while Eli Lilly And Co trades at $1,213.85 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 77.1× Aegon Ltd.'s market cap, and Aegon Ltd. pays the higher dividend (4.94%). Which is the better fit depends on your goals.
| AEG | LLY | |
|---|---|---|
Market Cap | $14.01B | $1.08T |
Sector | Financials | Health |
52-Week High | $9.53 | $1.24K |
52-Week Low | $6.79 | $639.43 |
Enterprise Value | $15.16B | $1.13T |
Dividend Yield | 4.94% | 0.57% |
Trailing returns across standard periods
Latest headlines on both assets
Aegon is a Netherlands-headquartered insurance company with core operations that stretch across the U.S., Netherlands, and United Kingdom. The business also holds peripheral ventures in Spain, Portugal, Brazil, and China.
Read more on AEG →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →